Raymond James & Associates’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,828
Closed -$94.1K 3971
2023
Q3
$94.1K Hold
20,828
﹤0.01% 3606
2023
Q2
$123K Hold
20,828
﹤0.01% 3584
2023
Q1
$110K Buy
+20,828
New +$141K ﹤0.01% 3629
2022
Q4
Sell
-11,283
Closed -$93K 4089
2022
Q3
$93K Sell
11,283
-328
-3% -$3.31K ﹤0.01% 3623
2022
Q2
$126K Sell
11,611
-1,027
-8% -$12.3K ﹤0.01% 3633
2022
Q1
$182K Buy
+12,638
New +$215K ﹤0.01% 3694

Other funds holding EXAI

Raymond James & Associates's EXAI Position: Q4 2023 in Review

Raymond James & Associates sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2023, closing a stake of 20,828 shares — an estimated $94.1K sold.

Raymond James & Associates first reported a position in EXAI in Q1 2022 and held it in 6 quarters. The position peaked at $182K in Q1 2022. 78 funds tracked by Wall St. Rank hold EXAI as of Q4 2023.

  • Raymond James & Associates reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 20,828 Exscientia Plc American Depositary Shares shares in Q4 2023, an estimated $94.1K.
  • Raymond James & Associates first reported a position in Exscientia Plc American Depositary Shares in Q1 2022 and held it in 6 quarters.
  • Raymond James & Associates's Exscientia Plc American Depositary Shares position peaked at $182K in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.